Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Studied Torn Rotator Cuff: Comparison Table

Before considering any intervention for rotator cuff injury, understanding how BPC-157 compares to standard treatments and other emerging therapies is essential. The table below contrasts mechanism, evidence quality, typical timelines, and clinical availabilit

This comparison does not assign a generated winner or score.

  • Before considering any intervention for rotator cuff injury, understanding how BPC-157 compares to standard treatments and other emerging therapies is essential. The table below contrasts mechanism, evidence quality, typical timelines, and clinical availability.
  • BPC-157
  • Stimulates fibroblast proliferation, angiogenesis, collagen synthesis via FAK-paxillin and VEGF pathways
  • Animal studies only. No Phase 3 human trials
  • Unknown in humans; animal models show 30–50% faster healing at 14–28 days
  • Research-grade peptide suppliers; not FDA-approved for human use
  • Mechanistically promising but unproven in human rotator cuff injuries. All current claims extrapolate from rat tendon models
  • Surgical Repair
  • Mechanical reattachment of torn tendon to bone using suture anchors
  • Gold standard for full-thickness tears; large body of clinical outcome data
  • 4–6 months to functional recovery; 9–12 months for full strength
  • Widely available via orthopedic surgeons
  • Still the definitive treatment for complete tears. Success rate 70–90% depending on tear size and tissue quality
  • PRP Injections
  • Platelet-derived growth factors promote collagen synthesis and reduce inflammation
  • Mixed evidence; some trials show benefit, others no difference vs placebo
  • 6–12 weeks for symptom improvement; does not repair complete tears
  • Available through sports medicine and regenerative clinics
  • May augment healing in partial tears or post-surgery. Should not replace surgical repair for full-thickness tears
  • Physical Therapy
  • Strengthens surrounding musculature, restores range of motion, reduces compensatory strain
  • Strong evidence for partial tears and non-operative management
  • 8–16 weeks for symptom reduction in partial tears
  • Widely available
  • First-line treatment for partial tears and post-surgical recovery. Cannot heal complete tears but prevents re-injury
More references

Related material